Glycerol-3-phosphate acyltransferase-4-deficient mice are protected from diet-induced insulin resistance by the enhanced association of mTOR and rictor

American Journal of Physiology - Endocrinology and Metabolism

Volumn 307, Issue 3, 2014, Pages

  Zhang, Chongben ^a   Cooper, Daniel E ^a   Grevengoed, Trisha J ^a   Li, Lei O ^a   Klett, Eric L ^b   Eaton, James M ^c   Harris, Thurl E ^c   Coleman, Rosalind A ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Diabetes; Glycerolipids; Insulin signaling; Lipid metabolism; Mammalian target of rapamycin complex 2; Phosphatidic acid

Indexed keywords

GLUCOSE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE 4; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHATIDIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; GENOTYPE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; GLYCOGEN SYNTHESIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIVER CELL; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WESTERN BLOTTING;

DIABETES; GLYCEROLIPIDS; INSULIN SIGNALING; LIPID METABOLISM; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHATIDIC ACID;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; DIET, HIGH-FAT; FEMALE; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; HEPATOCYTES; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; PHOSPHATIDIC ACIDS; RECOMBINANT PROTEINS; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84907190547     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00034.2014     Document Type: Article

References (39)

1. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551, 1996.
2. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868, 1999.
3. Cao J, Cheng L, Shi Y. Catalytic properties of MGAT3, a putative triacylgycerol synthase. J Lipid Res 48: 583-591, 2007.
4. Chang YY, Kennedy EP. Biosynthesis of phosphatidyl glycerophosphate in Escherichia coli. J Lipid Res 8: 447-455, 1967.
5. Chavez JA, Summers SA. A ceramide-centric view of insulin resistance. Cell Metab 15: 585-594, 2012.
6. Chen Y, Kuo MS, Li S, Bui HH, Peake DA, Sanders PE, Thibodeaux SJ, Chu S, Qian YW, Zhao Y, Bredt DS, Moller DE, Konrad RJ, Beigneux AP, Young SG, Cao G. AGPAT6 is a novel microsomal glycerol-3-phosphate acyltransferase (GPAT). J Biol Chem 283: 10048-10057, 2008.
7. Cheng Z, White MF. Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal 14: 649-661, 2011.
8. Coleman RA, Mashek DG. Mammalian triacylglycerol metabolism: Synthesis, lipolysis, and signaling. Chem Rev 111: 6359-6386, 2011.
9. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995.
10. Fang Y, Park IH, Wu AL, Du G, Huang P, Frohman MA, Walker SJ, Brown HA, Chen J. PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Curr Biol 13: 2037-2044, 2003.
11. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294: 1942-1945, 2001.
12. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
13. Garcia-Martinez JM, Alessi DR. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum-and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416: 375-385, 2008.
14. Hammond LE, Gallagher PA, Wang S, Posey-Marcos E, Hiller S, Kluckman K, Maeda N, Coleman RA. Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol Cell Biol 22: 8204-8214, 2002.
15. Iizuka K. Recent progress on the role of ChREBP in glucose and lipid metabolism. Endocr J 60: 543-555, 2013.
16. Johnson AM, Olefsky JM. The origins and drivers of insulin resistance. Cell 152: 673-684, 2013.
17. Kim JH, Kim JE, Liu HY, Cao W, Chen J. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. J Biol Chem 283: 708-715, 2008.
18. Le Floch JP, Escuyer P, Baudin E, Baudon D, Perlemuter L. Blood glucose area under the curve. Methodological aspects. Diabetes Care 13: 172-175, 1990.
19. Li LO, Klett EL, Coleman RA. Acyl-CoA synthesis, lipid metabolism and lipotoxicity. Biochim Biophys Acta 1801: 246-251, 2010.
20. Mayer CM, Belsham DD. Insulin directly regulates NPY and AgRP gene expression via the MAPK MEK/ERK signal transduction pathway in mHypoE-46 hypothalamic neurons. Mol Cell Endocrinol 307: 99-108, 2009.
21. Murphy RC, James PF, McAnoy AM, Krank J, Duchoslav E, Barkley RM. Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry. Anal Biochem 366: 59-70, 2007.
22. Nagle CA, An J, Shiota M, Torres TP, Cline GW, Liu ZX, Wang S, Catlin RL, Shulman GI, Newgard CB, Coleman RA. Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance. J Biol Chem 282: 14807-14815, 2007.
23. Nagle CA, Verges L, Wang S, deJong H, Wang S, Lewin TM, Reue K, Coleman RA. Identification of a novel sn-glycerol-3-phosphate acyltransferase isoform, GPAT4 as the enzyme deficient in Agpat6-/-mice. J Lipid Res 49: 823-831, 2008.
24. Neschen S, Morino K, Hammond LE, Zhang D, Liu ZX, Romanelli AJ, Cline GW, Pongratz RL, Zhang XM, Choi CS, Coleman RA, Shulman GI. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knock out mice. Cell Metab 2: 55-65, 2005.
25. Reaven Banting lecture 1988 GM. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
26. Romanelli A, Dreisbach VC, Blenis J. Characterization of phosphatidylinositol 3-kinase-dependent phosphorylation of the hydrophobic motif site Thr(389) in p70 S6 kinase 1. J Biol Chem 277: 40281-40289, 2002.
27. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871, 2012.
28. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101, 2005.
29. Shan D, Li JL, Wu L, Li D, Hurov J, Tobin JF, Gimeno RE, Cao J. GPAT3 and GPAT4 are regulated by insulin-stimulated phosphorylation and play distinct roles in adipogenesis. J Lipid Res 51: 1971-1981, 2010.
30. Stapleton CM, Mashek DG, Wang S, Nagle CA, Cline GW, Thuillier P, Leesnitzer LM, Li LO, Stimmel JB, Shulman GI, Coleman RA. Lysophosphatidic acid activates peroxisome proliferator activated receptor-gamma in CHO cells that overexpress glycerol 3-phosphate acyltransferase-1. PLos ONE 6: e18932, 2011.
31. Tang W, Yuan J, Chen X, Gu X, Luo K, Li J, Wan B, Wang Y, Yu L. Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway. J Biochem Mol Biol 39: 626-635, 2006.
32. Tremblay F, Gagnon A, Veilleux A, Sorisky A, Marette A. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology 146: 1328-1337, 2005.
33. Um SH, D'Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3: 393-402, 2006.
34. Vergnes L, Beigneux AP, Davis RG, Watkins SM, Young SG, Reue K. Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J Lipid Res 47: 745-754, 2006.
35. Wakimoto K, Chiba H, Michibata H, Seishima M, Kawasaki S, Okubo K, Mitsui H, Torii H, Imai Y. A novel diacylglycerol acyltransferase (DGAT2) is decreased in human psoriatic skin and increased in diabetic mice. Biochem Biophys Res Commun 310: 296-302, 2003.
36. Welsh GI, Wilson C, Proud CG. GSK3: a SHAGGY frog story. Trends Cell Biol 6: 274-279, 1996.
37. Wendel AA, Cooper DE, Ilkayeva OR, Muoio DM, Coleman RA. Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation. J Biol Chem 288: 27299-27306, 2013.
38. Wendel AA, Li LO, Li Y, Cline GW, Shulman GI, Coleman RA. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity. Diabetes 59: 1321-1329, 2010.
39. Zhang C, Wendel AA, Keogh MR, Harris TE, Chen J, Coleman RA. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Proc Natl Acad Sci USA 109: 1667-1672, 2012.